Form 4 Filing: Niklason Laura E Acquires (Grant) shares of $HUMA

STOCK AWARD / GRANT

⚡ MATERIALITY: 2/10

corporate issuer

Humacyte, Inc.

Ticker: $HUMA

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-11

Shares: 80,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Niklason Laura E, holds the title of President, CEO and Director at Humacyte, Inc..

On 2026-06-11, the insider transacted 80,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Niklason Laura E (President, CEO and Director) was granted $0 of $HUMA

Post-Transaction Position: 80,000 shares

SEC Accession No: 0001104659-26-073615 (CIK: 1878075)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$HUMA Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$HUMA News Coverage